Literature DB >> 24310047

Spinal epidural hematoma after spinal cord stimulator trial lead placement in a patient taking aspirin.

Asokumar Buvanendran1, Adam C Young.   

Abstract

OBJECTIVE: Spinal epidural hematoma is a rare, but potentially devastating, consequence of accessing the epidural space for anesthesia or interventional pain procedures. There is no consensus to stop aspirin therapy before interventional chronic pain procedures. CASE REPORT: A 73-year-old woman with postlaminectomy pain syndrome and lumbar radiculopathy underwent percutaneous spinal cord stimulator lead placement. She had been taking aspirin 81 mg/d for several years. Twenty-four hours later, she developed an epidural hematoma. Prompt recognition and surgical management resulted in no long-term neurological sequelae.
CONCLUSIONS: The only variable that could have led to our patient's epidural hematoma is aspirin. This is the first reported case of aspirin leading to an epidural hematoma following an interventional chronic pain procedure. Prior to interventional pain procedures, one should contemplate cessation of aspirin therapy because there are, at present, no consensus guidelines to direct such a decision.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24310047     DOI: 10.1097/AAP.0000000000000029

Source DB:  PubMed          Journal:  Reg Anesth Pain Med        ISSN: 1098-7339            Impact factor:   6.288


  5 in total

Review 1.  Novel Therapies for the Treatment of Neuropathic Pain: Potential and Pitfalls.

Authors:  Pottathil Shinu; Mohamed A Morsy; Anroop B Nair; Abdulaziz K Al Mouslem; Katharigatta N Venugopala; Manoj Goyal; Monika Bansal; Shery Jacob; Pran Kishore Deb
Journal:  J Clin Med       Date:  2022-05-26       Impact factor: 4.964

2.  Limitations of spinal cord stimulation for pain management.

Authors:  Jae Hang Shim
Journal:  Korean J Anesthesiol       Date:  2015-08

Review 3.  Neuraxial and peripheral nerve blocks in patients taking anticoagulant or thromboprophylactic drugs: challenges and solutions.

Authors:  Jinlei Li; Thomas Halaszynski
Journal:  Local Reg Anesth       Date:  2015-08-04

4.  Are there a guidelines for implantable spinal cord stimulator therapy in patients using chronic anticoagulation therapy? - A review of decision-making in the high-risk patient.

Authors:  Ramsis F Ghaly; Alexei Lissounov; Kenneth D Candido; Nebojsa Nick Knezevic
Journal:  Surg Neurol Int       Date:  2016-04-07

5.  Spinal Cord Stimulator Explant and Revision Complicated by Syrinx Formation: A Case Report and Literature Review.

Authors:  Sameer S Ali; Ilya Bragin; Arjumond Y Khan; Hajime Tokuno; Pavan Tankha
Journal:  Cureus       Date:  2019-08-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.